Opus Point Partners Management »

Ascendis Pharma A S shares owned by Opus Point Partners Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Opus Point Partners Management from 13F filings

Historical chart of Opus Point Partners Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Opus Point Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Opus Point Partners Management

Quarter filed Position value Share count Share price at filing
2019-09-30 $596k 6.2k 96.28
2019-06-30 $713k 6.2k 115.19
2019-03-31 $729k 6.2k 117.77

More positions owned by Opus Point Partners Management

iShares NASDAQ Biotechnology Index (IBB)
Direxion Shs Etf Tr sp biotch bl
Mettler-Toledo International (MTD)
Bristol Myers Squibb (BMY)
Seattle Genetics
Illumina (ILMN)
Vertex Pharmaceuticals Incorporated (VRTX)
Ionis Pharmaceuticals (IONS)
Alnylam Pharmaceuticals (ALNY)
Alexion Pharmaceuticals
Qiagen Nv
Spark Therapeutics
Fortress Biotech
Proqr Thrapeutics N V shs euro (PRQR)
Incyte Corporation (INCY)

View all positions for Opus Point Partners Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
Massachusetts Financial Services
T. Rowe Price Associates
Franklin Resources
Brown Advisory Holdings Incorporated
Alliancebernstein
TimesSquare Capital Management
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Paradigm Biocapital Advisors

View all funds holding Ascendis Pharma A S